Abstract
Abstract
Background
Von Hippel-Lindau (VHL) syndrome is a familial autosomal dominant hereditary neoplastic disease caused by mutations in the VHL gene. Approximately 503 kinds of VHL gene mutations have been reported. Different types of mutations manifest various clinical phenotypes, from benign to malignant tumours or coexisting cysts. Thus, a gene mutation test is essential in the diagnosis of VHL syndrome.
Case presentation
We reported two cases in which a novel mutation site in the c530-536delGACTGGA region in exon 3 of the VHL gene resulted in the development of VHL syndrome. According to the ACMG guidelines, this variation is pathogenic and consistent with autosomal dominant inheritance. This variation has not been reported anywhere in the databases or literature.
Conclusion
This report will add a new mutation site to VHL gene databases. The newly added gene mutation and its associated clinical phenotypes will help improve the accuracy of VHL diagnosis and benefit the community of VHL gene mutation carriers.
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics
Reference15 articles.
1. Zhang J, Wu D, Ai H, et al. Epidemiological study of a von Hippel-Lindau family in Northwest China. Front Med. 2013;7(3):378–85.
2. Richard S, Gardie B, Couvé S, et al. Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 2013;23(1):26–37.
3. Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E, et al. Genetic analysis of von Hippel Lindau disease. Hum Mutat. 2010;31(5):521–37.
4. Albiges L, Choueiri T, Escudier B, et al. A systematic review of sequencing and combinations of systemic therapy in metastatic renal Cancer. Eur Urol. 2015;67(1):100–10.
5. Chou A, Toon C, Pickett J, et al. Von hippel-lindau syndrome. Front Horm Res. 2013;41:30–49.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献